Quality indicators for sentinel lymph node biopsy: Is there room for improvement?

Canadian Journal of Surgery

Volumn 56, Issue 2, 2013, Pages 82-88

  Acuna, Sergio A ^a,b   Angarita, Fernando A ^a,b,c   McCready, David R ^a,c,d   Escallon, Jaime ^a,c,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876160710     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.033011     Document Type: Article

References (33)

1. Tabár L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000;38:625-51.
2. Henley SJ, King JB, German RR, et al. Surveillance of screeningdetected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006. MMWR Surveill Summ 2010;59:1-25.
3. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8.
4. Hortobagyi GN, de la Garza SJ, Pritchard K, et al. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 2005;6:391-401.
5. Veronesi U, Galimberti V, Zurrida S, et al. Prognostic significance of number and level of axillary node metastases in breast cancer. Breast 1993;2:224-8.
6. Schachter HM, Mamaladze V, Lewin G, et al. Many quality measurements, but few quality measures assessing the quality of breast cancer care in women: a systematic review. BMC Cancer 2006;6:291.
7. Birkmeyer JD, Dimick JB, Birkmeyer NJ. Measuring the quality of surgical care: Structure, process, or outcomes? J Am Coll Surg 2004;198: 626-32.
8. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-20.
9. Quan ML, Wells BJ, McCready D, et al. Beyond the false negative rate: development of quality indicators for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 2010;17:579-91.
10. Simmons RM. Review of sentinel lymph node credentialing: How many cases are enough? J Am Coll Surg 2001;193:206-9.
11. Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 2009;133:1515-38.
12. Fitzgibbons PL, Connolly JL, Page DL; Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Northfield (IL): College of American Pathologists; 2005. Available: www.cap.org/apps/docs/committees/cancer/cancer- protocols/2005/breast05-pw.pdf (accessed 2011 Nov. 17).
13. Lester SC, Bose S, Chen Y, et al.; Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Northfield (IL): College of American Pathologists; 2009. Available: www .cap .org/apps/docs/committees/cancer/cancer protocols/2009/InvasiveBreast09protocol .pdf (accessed 2011 Nov. 17).
14. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003;10: 1140-51.
15. Wells BJ, Najjar H, Wright FC, et al. Measuring the quality of sentinel lymph node biopsy in breast cancer using newly developed quality indicators: a feasibility study. Ann Surg Oncol 2011;18:78-85.
16. Rescigno J, Zampell JC, Axelrod D. Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy. Ann Surg Oncol 2009;16:687-96.
17. Krikanova M, Biggar M, Moss D, et al. Accuracy of sentinel node biopsy for breast cancer using blue dye alone. Breast J 2010;16:384-8.
18. Gill PG, Luke CG, Roder DM. Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer. Breast 2006;15:640-8.
19. Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001;192:684-9.
20. Hansen NM, Grube B, Ye X, et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 2009; 27:4679-84.
21. Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006;7:983-90.
22. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553-9.
23. Chung MA, Steinhoff MM, Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002;184:310-4.
24. van der Ploeg IM, Nieweg OE, van Rijk MC, et al. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008;34:1277-84.
25. Haigh PI, Hansen NM, Qi K, et al. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 2000;7:21-7.
26. Haid A, Köberle-Wührer R, Knauer M, et al. Morbidity of breast cancer patients following complete axillary dissection on sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2002; 73:31-6.
27. Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001;37:991-9.
28. Conn CA, McMasters KM, Edwards MJ, et al. Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in Kentucky. Breast J 2005;11:231-5.
29. Bevers TB, Anderson BO, Bonaccio E, et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw 2009;7:1060-96.
30. The requirements of a specialist breast unit. Eur J Cancer 2000;36: 2288-93.
31. Malin JL, Schneider EC, Epstein AM, et al. Results of the National Initiative for Cancer Care Quality: How can we improve the quality of cancer care in the United States? J Clin Oncol 2006;24:626-34.
32. Landercasper J, Dietrich LL, Johnson JM. A breast center review of compliance with National Comprehensive Cancer Network Breast Cancer guidelines. Am J Surg 2006;192:525-7.
33. Cheng SH, Wang CJ, Lin JL, et al. Adherence to quality indicators and survival in patients with breast cancer. Med Care 2009;47:217-25.